Synopsis
0
JDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
44
PharmaCompass offers a list of Sodium Ascorbate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sodium Ascorbate manufacturer or Sodium Ascorbate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Ascorbate manufacturer or Sodium Ascorbate supplier.
A E301 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of E301, including repackagers and relabelers. The FDA regulates E301 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. E301 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of E301 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A E301 supplier is an individual or a company that provides E301 active pharmaceutical ingredient (API) or E301 finished formulations upon request. The E301 suppliers may include E301 API manufacturers, exporters, distributors and traders.
click here to find a list of E301 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A E301 DMF (Drug Master File) is a document detailing the whole manufacturing process of E301 active pharmaceutical ingredient (API) in detail. Different forms of E301 DMFs exist exist since differing nations have different regulations, such as E301 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A E301 DMF submitted to regulatory agencies in the US is known as a USDMF. E301 USDMF includes data on E301's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The E301 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of E301 suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a E301 Drug Master File in Korea (E301 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of E301. The MFDS reviews the E301 KDMF as part of the drug registration process and uses the information provided in the E301 KDMF to evaluate the safety and efficacy of the drug.
After submitting a E301 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their E301 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of E301 suppliers with KDMF on PharmaCompass.
A E301 CEP of the European Pharmacopoeia monograph is often referred to as a E301 Certificate of Suitability (COS). The purpose of a E301 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of E301 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of E301 to their clients by showing that a E301 CEP has been issued for it. The manufacturer submits a E301 CEP (COS) as part of the market authorization procedure, and it takes on the role of a E301 CEP holder for the record. Additionally, the data presented in the E301 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the E301 DMF.
A E301 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. E301 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of E301 suppliers with CEP (COS) on PharmaCompass.
A E301 written confirmation (E301 WC) is an official document issued by a regulatory agency to a E301 manufacturer, verifying that the manufacturing facility of a E301 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting E301 APIs or E301 finished pharmaceutical products to another nation, regulatory agencies frequently require a E301 WC (written confirmation) as part of the regulatory process.
click here to find a list of E301 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing E301 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for E301 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture E301 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain E301 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a E301 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of E301 suppliers with NDC on PharmaCompass.
E301 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of E301 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right E301 GMP manufacturer or E301 GMP API supplier for your needs.
A E301 CoA (Certificate of Analysis) is a formal document that attests to E301's compliance with E301 specifications and serves as a tool for batch-level quality control.
E301 CoA mostly includes findings from lab analyses of a specific batch. For each E301 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
E301 may be tested according to a variety of international standards, such as European Pharmacopoeia (E301 EP), E301 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (E301 USP).
